About Animal Vaccines
Animal vaccines are biological preparations used to improve the immunity of animals. Animal vaccines are generally prepared from weakened or dead microbes that can cause a particular disease when in their healthy state. Some of the animal vaccines are also formulated using a part of a microbe's body such as protein subunits or toxic components. These components act as stimulating agents that trigger the immune system in an animal body. This then prepares the necessary antibodies to act against the microbes present in the body or to destroy any that it encounters in the future. Based on their applications, animal vaccines are predominantly categorized into livestock vaccines, companion vaccines, and aquaculture vaccines.
TechNavio's analysts forecast the Global Animal Vaccines market to grow at a CAGR of 8.25 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Animal Vaccines market for the period 2014–2018. To calculate the market size, the report considers the revenue generated from the sales of various animal vaccines. In terms of vaccines types, the Global Animal Vaccines market can be segmented into six: Companion Animal Vaccines, Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Equine Vaccines, and Other Animal Vaccines.
TechNavio's report, the Global Animal Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Animal Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Bayer HealthCare
• Elanco Animal Health
• Merck Animal Health
• Novartis Animal Health
• Sanofi
• Zoetis
Other Prominent Vendors
• BioCell
• Biogenesis Bago
• Boehringer Ingelheim
• Ceva Santé Animale
• Heska
• Imugene
• Indian Immunologicals
• Lohmann Animal Health International
• Virbac
Market Driver
• Growing Prevalence of Animal Diseases
• For a full, detailed list, view our report
Market Challenge
• Increase in Vaccine Maintenance Costs
• For a full, detailed list, view our report
Market Trend
• Increase in Acquisitions
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Products
07.1 Global Livestock Vaccines Market
07.1.1 Market Size and Forecast
07.2 Global Companion Animal Vaccines Market
07.2.1 Market Size and Forecast
07.3 Global Porcine Vaccines Market
07.3.1 Market Size and Forecast
07.4 Global Poultry Vaccines Market
07.4.1 Market Size and Forecast
07.5 Global Equine Vaccines Market
07.5.1 Market Size and Forecast
07.6 Global Other Animals Vaccines Market
07.6.1 Market Size and Forecast
08. Market Segmentation by Technology
09. Geographical Segmentation
09.1 Animal Vaccines Market in Americas
09.1.1 Market Size and Forecast
09.2 Animal Vaccines Market in the EMEA Region
09.2.1 Market Size and Forecast
09.3 Animal Vaccines Market in the APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
17.4 Bayer Healthcare
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation by Revenue 2013
17.4.4 Business Segmentation by Revenue 2012 and 2013
17.4.5 Geographical Segmentation by Revenue 2013
17.4.6 Business Strategy
17.4.7 Recent Developments
17.4.8 SWOT Analysis
17.4.9 Strengths
17.4.10 Weaknesses
17.4.11 Opportunities
17.4.12 Threats
17.5 Elanco Animal Health
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Strategy
17.5.4 Recent Developments
17.5.5 SWOT Analysis
17.5.6 Strengths
17.5.7 Weaknesses
17.5.8 Opportunities
17.5.9 Threats
17.6 Merck Animal Health
17.6.1 Key Facts
17.6.2 Business Overview
17.6.3 Business Strategy
17.6.4 Recent Developments
17.6.5 SWOT Analysis
17.6.6 Strengths
17.6.7 Weaknesses
17.6.8 Opportunities
17.6.9 Threats
17.7 Novartis Animal Health
17.7.1 Key Facts
17.7.2 Business Overview
17.7.3 Product Segmentation
17.7.4 Geographical Segmentation
17.7.5 Business Strategy
17.7.6 Recent Developments
17.7.7 SWOT Analysis
17.7.8 Strengths
17.7.9 Weaknesses
17.7.10 Opportunities
17.7.11 Threats
17.8 Sanofi
17.8.1 Key Facts
17.8.2 Business Overview
17.8.3 Business Segmentation by Revenue 2013
17.8.4 Business Segmentation by Revenue 2012 and 2013
17.8.5 Geographical Segmentation by Revenue 2013
17.8.6 Business Strategy
17.8.7 Key Developments
17.8.8 SWOT Analysis
17.8.9 Strengths
17.8.10 Weakness
17.8.11 Opportunities
17.8.12 Threats
17.9 Zoetis
17.9.1 Key Facts
17.9.2 Business Overview
17.9.3 Business Segmentation by Revenue 2013
17.9.4 Business Segmentation by Revenue 2012 and 2013
17.9.5 Geographical Segmentation by Revenue 2013
17.9.6 Business Strategy
17.9.7 Recent Developments
17.9.8 SWOT Analysis
17.9.9 Strengths
17.9.10 Weaknesses
17.9.11 Opportunities
17.9.12 Threats
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Animal Vaccines Market 2013-2018 (US$ billion)
Exhibit 3: Global Animal Vaccines Market Segmentation by Product
Exhibit 4: Global Animal Vaccines Market by Market Segmentation 2013
Exhibit 5: Global Livestock Vaccines Market 2013-2018 (US$ billion)
Exhibit 6: Global Companion Animal Vaccines Market 2013-2018 (US$ billion)
Exhibit 7: Global Porcine Vaccines Market 2013-2018 (US$ billion)
Exhibit 8: Global Poultry Vaccines Market 2013-2018 (US$ billion)
Exhibit 9: Global Equine Vaccines Market 2013-2018 (US$ billion)
Exhibit 10: Global Other Animals Vaccines Market 2013-2018 (US$ billion)
Exhibit 11: Global Animal Vaccines Market 2013-2018 (in revenue)
Exhibit 12: Global Animal Vaccines Market 2013-2018 (in percent)
Exhibit 13: Global Animals Vaccines Market Segmentation by Technology
Exhibit 14: Global Animal Vaccines Market by Geographical Segmentation 2013
Exhibit 15: Animal Vaccines Market in Americas 2013-2018 (US$ billion)
Exhibit 16: Animal Vaccines Market in the EMEA Region
Exhibit 17: Animal Vaccines Market in the APAC Region
Exhibit 18: Global Animal Vaccine Market by Geographical Segmentation 2013-2018 (in percent)
Exhibit 19: Zoetis Revenue Segmentation by Geography
Exhibit 20: Zoetis Market Revenue by Species
Exhibit 21: Merck Animal Health by Revenue Segments
Exhibit 22: Sanofi by Revenue Segments
Exhibit 23: Bayer Healthcare: Business Segmentation by Revenue 2013
Exhibit 24: Bayer Healthcare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 25: Bayer Healthcare: Geographical Segmentation by Revenue 2013
Exhibit 26: Novartis Animal Health: Product Segmentation
Exhibit 27: Novartis Animal Health: Geographical Segmentation
Exhibit 28: Sanofi: Business Segmentation by Revenue 2013
Exhibit 29: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 30: Sanofi: Geographical Segmentation by Revenue 2013
Exhibit 31: Zoetis: Business Segmentation by Revenue 2013
Exhibit 32: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 33: Zoetis: Geographical Segmentation by Revenue 2013
